Viela Bio, Inc. (VIE) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for VIE in the last 30 days. The most recent was published Mar 25, 2021.
Latest news
25 items- SECSEC Form 15-12B filed by Viela Bio, Inc.15-12B - Viela Bio, Inc. (0001734517) (Filer)
- 13D/GSEC Form SC 13D/A filed by Viela Bio, Inc.SC 13D/A - Viela Bio, Inc. (0001734517) (Subject)
- INSIDERSEC Form 4: Yanling Cao disposed to the issuer $441,084,709 worth of Common Stock (8,322,353 units at $53.00)4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4 filed by Tyrell Rivers4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4 filed by Plc Astrazeneca4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: Andreas Wicki disposed to the issuer $92,750,000 worth of Common Stock (1,750,000 units at $53.00)4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: Edward Hu disposed to the issuer $220,542,381 worth of Common Stock (4,161,177 units at $53.00)4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4 filed by Ltd Meadow Boundless4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: Mitchell Chan disposed to the issuer $1,987,500 worth of Common Stock (37,500 units at $53.00), decreasing direct ownership by 100% to 0 units4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: Jorn Drappa disposed to the issuer $10,741,033 worth of Common Stock (202,661 units at $53.00), decreasing direct ownership by 100% to 0 units4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4 filed by Paul James Kastenmayer4 - Viela Bio, Inc. (0001734517) (Issuer)
- SECSEC Form S-8 POS filed by Viela Bio, Inc.S-8 POS - Viela Bio, Inc. (0001734517) (Filer)
- INSIDERSEC Form 4 filed by Suzanne Rachelle Jacques4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4 filed by Chris Nolet4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: Zhengbin Yao disposed to the issuer $24,921,607 worth of Common Stock (470,219 units at $53.00), decreasing direct ownership by 100% to 0 units4 - Viela Bio, Inc. (0001734517) (Issuer)
- INSIDERSEC Form 4: William Ragatz disposed to the issuer $861,250 worth of Common Stock (16,250 units at $53.00), decreasing direct ownership by 100% to 0 units4 - Viela Bio, Inc. (0001734517) (Issuer)
- SECSEC Form S-8 POS filed by Viela Bio, Inc.S-8 POS - Viela Bio, Inc. (0001734517) (Filer)
- SECSEC Form POSASR filed by Viela Bio, Inc.POSASR - Viela Bio, Inc. (0001734517) (Filer)
- SECSEC Form 8-K filed by Viela Bio, Inc.8-K - Viela Bio, Inc. (0001734517) (Filer)
- SECSEC Form SC 14D9/A filed by Viela Bio, Inc.SC 14D9/A - Viela Bio, Inc. (0001734517) (Subject)
- SECSEC Form 25-NSE filed by Viela Bio, Inc.25-NSE - Viela Bio, Inc. (0001734517) (Subject)
- SECSEC Form SC TO-T/A filed by Viela Bio, Inc.SC TO-T/A - Viela Bio, Inc. (0001734517) (Subject)
- SECSEC Form SC TO-T/A filedSC TO-T/A - Viela Bio, Inc. (0001734517) (Subject)
- SECSEC Form SC 14D9/A filedSC 14D9/A - Viela Bio, Inc. (0001734517) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Viela Bio, Inc. (0001734517) (Subject)
VIE FAQ
6 questionsWhat is the latest news on VIE?
Quantisnow has not tracked any new filings, ratings or press releases for VIE in the last 30 days. The most recent wire item was published on March 25, 2021.Where does VIE stock trade?
Viela Bio, Inc. (VIE) is listed on NASDAQ.What sector and industry is VIE in?
Viela Bio, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.When did Viela Bio, Inc. go public?
Viela Bio, Inc. (VIE) completed its IPO in 2019.What companies are similar to VIE?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare VIE side-by-side with any of them on Quantisnow.How can I track VIE on Quantisnow?
Quantisnow aggregates Viela Bio, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VIE to receive live email and push alerts on every new disclosure.